Key Points
- COO Panagiotis Tsourapas sold a total of 50,000 Colgate shares on Feb 11–12 for about $4.78 million (35,000 at $94.61 and 15,000 at $97.81), leaving him with 10,415 shares—a roughly 59.02% reduction in his ownership.
- Colgate beat Q4 estimates with EPS of $0.95 vs. $0.91 and revenue of $5.23 billion (up 5.8% year‑over‑year); the company pays a $0.52 quarterly dividend (2.2% yield) and carries a consensus analyst rating of Moderate Buy with an average target of $94.38.
Colgate-Palmolive Company (NYSE:CL - Get Free Report) COO Panagiotis Tsourapas sold 15,000 shares of the business's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company's stock, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Panagiotis Tsourapas also recently made the following trade(s):
- On Wednesday, February 11th, Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00.
Colgate-Palmolive Stock Up 0.5%
CL stock opened at $96.61 on Friday. The company has a market cap of $77.87 billion, a price-to-earnings ratio of 36.87, a P/E/G ratio of 4.34 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. The business's 50-day moving average is $83.80 and its two-hundred day moving average is $81.90. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the company posted $0.91 EPS. The business's quarterly revenue was up 5.8% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive's dividend payout ratio is currently 79.39%.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on CL shares. Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. Argus reissued a "hold" rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Morgan Stanley raised their price objective on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an "overweight" rating in a research note on Monday, February 2nd. JPMorgan Chase & Co. boosted their price objective on Colgate-Palmolive from $93.00 to $97.00 and gave the company an "overweight" rating in a research note on Monday, February 2nd. Finally, Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an "equal weight" rating in a research note on Sunday, February 1st. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $94.38.
Get Our Latest Research Report on CL
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in CL. Jacobi Capital Management LLC grew its stake in Colgate-Palmolive by 5.8% in the 4th quarter. Jacobi Capital Management LLC now owns 10,543 shares of the company's stock worth $833,000 after acquiring an additional 581 shares in the last quarter. CreativeOne Wealth LLC raised its stake in shares of Colgate-Palmolive by 7.6% during the fourth quarter. CreativeOne Wealth LLC now owns 16,087 shares of the company's stock valued at $1,271,000 after acquiring an additional 1,140 shares in the last quarter. Kestra Advisory Services LLC boosted its holdings in shares of Colgate-Palmolive by 2.2% in the fourth quarter. Kestra Advisory Services LLC now owns 40,463 shares of the company's stock valued at $3,197,000 after purchasing an additional 885 shares during the period. Ontario Teachers Pension Plan Board grew its stake in Colgate-Palmolive by 7.3% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 40,234 shares of the company's stock worth $3,179,000 after purchasing an additional 2,732 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in Colgate-Palmolive by 2.2% during the 4th quarter. The Manufacturers Life Insurance Company now owns 816,427 shares of the company's stock worth $64,689,000 after purchasing an additional 17,771 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.
Colgate-Palmolive Company Profile
(
Get Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
